Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Breast Cancer Research : BCR
|
July 2, 2025
Retrospective comparison between breast cancer tissue- and blood-based next-generation sequencing results in detection of PIK3CA, AKT1, and PTEN alterations
Moumita Chaki, Mona Benrashid, Subir Puri, et al.
Journal of Hematology & Oncology
|
May 29, 2026
Circulating tumor DNA in breast cancer: updates from SABCS 2025
Iris Zhi, Xianghui Zou, Min Sun, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 30, 2025
Clinicogenomic landscape and function of <i>PIK3CA</i> , <i>AKT1</i> , and <i>PTEN</i> mutations in breast cancer
Jacqueline J Tao, Saumya D Sisoudiya, Hanna Tukachinsky, et al.
JCO Precision Oncology
|
April 9, 2026
Clinicogenomic Landscape and Function of <i>PIK3CA</i>, <i>AKT1</i>, and <i>PTEN</i> Mutations in Breast Cancer
Jacqueline J Tao, Saumya D Sisoudiya, Hanna Tukachinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2023
Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations
Smruthy Sivakumar, Dexter X Jin, Ruchita Rathod, et al.
Research Square
|
August 13, 2025
A Hotspot Phosphorylation Site on SHP2 Drives Oncoprotein Activation and Drug Resistance
Prashath Karunaraj, Remkes Scheele, Malcolm L Wells, et al.
The Oncologist
|
October 14, 2024
Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations
Faiza Yasin, Ethan Sokol, Neil Vasan, et al.
Integrative Cancer Therapies
|
July 14, 2021
Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series
Tahj Blow, Parker N Hyde, John N Falcone, et al.
The Oncologist
|
April 9, 2014
A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice
Neil Vasan, Roman Yelensky, Kai Wang, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
A Hotspot Phosphorylation Site on SHP2 Drives Oncoprotein Activation and Drug Resistance
Prashath Karunaraj, Remkes Scheele, Malcolm L Wells, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Breast Cancer Research : BCR
|
July 2, 2025
Retrospective comparison between breast cancer tissue- and blood-based next-generation sequencing results in detection of PIK3CA, AKT1, and PTEN alterations
Moumita Chaki, Mona Benrashid, Subir Puri, et al.
Journal of Hematology & Oncology
|
May 29, 2026
Circulating tumor DNA in breast cancer: updates from SABCS 2025
Iris Zhi, Xianghui Zou, Min Sun, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 30, 2025
Clinicogenomic landscape and function of <i>PIK3CA</i> , <i>AKT1</i> , and <i>PTEN</i> mutations in breast cancer
Jacqueline J Tao, Saumya D Sisoudiya, Hanna Tukachinsky, et al.
JCO Precision Oncology
|
April 9, 2026
Clinicogenomic Landscape and Function of <i>PIK3CA</i>, <i>AKT1</i>, and <i>PTEN</i> Mutations in Breast Cancer
Jacqueline J Tao, Saumya D Sisoudiya, Hanna Tukachinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2023
Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations
Smruthy Sivakumar, Dexter X Jin, Ruchita Rathod, et al.
Research Square
|
August 13, 2025
A Hotspot Phosphorylation Site on SHP2 Drives Oncoprotein Activation and Drug Resistance
Prashath Karunaraj, Remkes Scheele, Malcolm L Wells, et al.
The Oncologist
|
October 14, 2024
Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations
Faiza Yasin, Ethan Sokol, Neil Vasan, et al.
Integrative Cancer Therapies
|
July 14, 2021
Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series
Tahj Blow, Parker N Hyde, John N Falcone, et al.
The Oncologist
|
April 9, 2014
A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice
Neil Vasan, Roman Yelensky, Kai Wang, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
A Hotspot Phosphorylation Site on SHP2 Drives Oncoprotein Activation and Drug Resistance
Prashath Karunaraj, Remkes Scheele, Malcolm L Wells, et al.
Page
of 4